PlexusDx serves all 50 states, making injectable weight loss therapy accessible to patients regardless of location or insurance status
In the past five years, research has found that GLP-1 drugs can lower the risk of a number of obesity-related chronic diseases such as heart disease, chronic kidney disease, sleep disorders, osteoarthritis and even certain cancers, with one study finding that people taking GLP-1 drugs had a lower risk of developing 42 different diseases than those given their usual medicines
The transition period is not the time for major dietary changes, as it introduces too many variables to evaluate how well the new medication is working
Tolerability of semaglutide was assessed through AEs, physical examination, electrocardiogram, vital signs, hypoglycemic events, plasma glucose, and clinical laboratory parameters (biochemistry, hematology, and urinalysis)
Will Wegovy be covered by insurance now
Forget long waits for appointments